India: A dangerous mushroom infection is attacking people cured by COVID-19

The second wave of coronary is affecting India, with the largest daily increase in new cases in the world, and doctors, except that they suffer from a large number of patients and insufficient hospital capacity, are also facing an increase in the rare mukosa mushrooms infection that attacks them [...]
It is a rare mushroom infection that is most often found on earth and rotten plants. A person is infected with spores, and the disease occurs in people with weakened immune systems or those with diabetes, use chronic cortichosteroids, have metabolic acids, or have transplanted organs.
It attacks sinuses, eyes, brain and lungs and can be fatal to diabetes or those with cancer and AIDS.
One of those struggling with this mushroom infection is a 25-year-old Indian woman with diabetes, who was recovered from the coronary three weeks ago.
She first underwent surgery yesterday by an ear, throat, and nose specialist, after which she underwent three hours of eye surgery.
I'll take my eye off to save my life. That's how this malady “works, doctor Akshay Nair told BBC.
He believes that in the case of a young Indian woman, mukormiosis, from which the mortality rate is 50 percent, is caused by steroids she received as part of COVID-19, which is usually described to patients with heavy or heavy coronarys.
Steroids reduce inflammation in the lungs when it comes to COVID-19 and have shown that it helps prevent injuries that can occur in the body when the immune system “is tested” in the fight against the coronary. But they can also cause an immune decline and increase blood sugar levels in both diabetes and non-diabetics with COVID.
Immunity reduction causes mucocosa
It is believed that this decline in immunity is a trigger for mukorikosis.
“Dialbet lowers body immune protection, coronary makes it worse, and steroids that help in the fight against COVID-19 adds fuel to fire”, said Narir, who works in three hospitals in Mumbai, one of the most hit cities in India by the Coronavirus epidemic.
He claimed that in April alone, there were 40 patients who received mukorikosis. Many were diabetics who were cured by COVID at home. 11 of them are subjected to eye - removal surgery.
From December to February, only six of his colleagues in five cities reported 58 cases of infection. Most patients earned it 12 to 15 days after being healed by the Coronobrus.
One of the hospitals in Mumbai has recorded 24 cases of mukorikosis in the past two months, which is a significant increase compared to the previous average of six cases a year. In those cases, 11 lost one eye and six died. Most patients are middle - aged diabetics who were infected two weeks after being recovered from COVID-19.
We are currently facing two to three cases a week. It's a real nightmare in the middle of a pandemic, “said medicine Renuda Bradoo near Mumbai Hospital.
Mucormicose Symptoms
Mukorikose patients more often have a busy nose or nosebleed, swelling and pain in the eye, a fall of eyelids, vague vision, and, ultimately, loss of sight. Black stains can also appear in the skin around the nose.
Doctors say that most patients with this infection occur very late, at a time when they are already losing sight and usually need to remove their eye so that the infection does not spread to the brain.
In some cases in India doctors claim that patients were both blind, and in rare cases, the jaws had to be removed to prevent the spread of the disease.
The only medicine that helps in this case is an injection that costs $48, and it should be taken every day for eight weeks. The only way to prevent thiscotic infection is to ensure that patients with COVID get steroids in the right dosage and time, both during treatment and during recovery, according to a doctor from Mumbai.











